Upcoming Global Web Symposia
February 11, 201511am-12:30pm est
Increasing efficiency and productivity for product titer quantification is even more critical as a result of increasing workloads in supporting multiple programs at different stages with limited resources. Current methods, such as ELISA and HPLC, create bottlenecks in critical workflows because of throughput constraints, limited dynamic range, and longer assay times. In addition, in process analytical testing needs to accommodate different sample types, matrices and a variety of conditions that are variable throughout cell line development and upstream development. Gyros’ technology provides a robust, reproducible alternative to improve analytical support to the ever increasing demands to control product quality and process consistency that is scalable at all stages of development and production. This webinar will focus on the use of automated, nanoliter-scale flow-through technology to address a critical need for improved speed and throughput with high data quality for product titer quantification.
Rapid Development of Gyrolab Titer ELISAs to Support Biopharmaceutical Process Development
Matt Traylor, Analytical Development, Shire Human Genetic Therapies
High Throughput Monoclonal Antibody Titer Assay for BioProcess Development
Jun Heo, Analytical Scientist, Bioprocess Technology and Expression (BTE), Merck & Co., Inc.
Meletios Roussis, Field Applications Scientist, Gyros US, Inc.
Schedule conflict? Register now and you'll receive a copy of the recording.
250 First Avenue, Suite 300
Needham, MA 02494
Biological Therapeutic Products
Biomarkers & Diagnostics
Bioprocess & Manufacturing
Clinical Trials & Translational Medicine
Drug & Device Safety
Drug Discovery & Development
IT & Informatics
Technology & Tools For Life Science
Cambridge Healthtech Institute
Cambridge Innovation Institute